Five-year Study By OHSU Cancer Institute Shows Gleevec's Excellent Survival Rate

... In five years Gleevec, the little yellow pill, has proved itself to be a miracle drug for most patients who take it.When the drug first was developed by Brian J. Druker, M.D., the leukemia program leader of the Oregon Health & Science University Cancer Institute, the overall survival rate for patients with chronic myelogenous leukemia (CML) taking this new experimental drug was unknown. [click link for full article] ...